714 related articles for article (PubMed ID: 31229700)
1. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
[TBL] [Abstract][Full Text] [Related]
2. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
3. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
[TBL] [Abstract][Full Text] [Related]
6. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
Fheodoroff K; Dressler D; Woldag H; Koßmehl P; Koch M; Maisonobe P; Reichel G
Nervenarzt; 2019 Apr; 90(4):361-370. PubMed ID: 30324541
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
Demetrios M; Gorelik A; Louie J; Brand C; Baguley IJ; Khan F
J Rehabil Med; 2014 Sep; 46(8):730-7. PubMed ID: 25073939
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
Ghroubi S; Alila S; Elleuch W; Ayed HB; Mhiri C; Elleuch MH
Pan Afr Med J; 2020; 35():55. PubMed ID: 32523646
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial.
Hokazono A; Etoh S; Jonoshita Y; Kawahira K; Shimodozono M
J Hand Ther; 2022; 35(4):507-515. PubMed ID: 33820711
[TBL] [Abstract][Full Text] [Related]
11. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
[TBL] [Abstract][Full Text] [Related]
12. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
[TBL] [Abstract][Full Text] [Related]
14. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
[TBL] [Abstract][Full Text] [Related]
16. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.
Lagalla G; Danni M; Reiter F; Ceravolo MG; Provinciali L
Am J Phys Med Rehabil; 2000; 79(4):377-84; quiz 391-4. PubMed ID: 10892624
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
Rousseaux M; Kozlowski O; Froger J
J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
[TBL] [Abstract][Full Text] [Related]
18. Combined therapeutic application of botulinum toxin type A, low-frequency rTMS, and intensive occupational therapy for post-stroke spastic upper limb hemiparesis.
Kakuda W; Abo M; Momosaki R; Yokoi A; Fukuda A; Ito H; Tominaga A; Umemori T; Kameda Y
Eur J Phys Rehabil Med; 2012 Mar; 48(1):47-55. PubMed ID: 22071503
[TBL] [Abstract][Full Text] [Related]
19. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
Pennati GV; Da Re C; Messineo I; Bonaiuti D
Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
[TBL] [Abstract][Full Text] [Related]
20. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
Nott MT; Barden HL; Baguley IJ
J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
